1. Home
  2. BATRA vs XENE Comparison

BATRA vs XENE Comparison

Compare BATRA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

N/A

Current Price

$56.42

Market Cap

3.7B

Sector

Industrials

ML Signal

N/A

Logo Xenon Pharmaceuticals Inc.

XENE

Xenon Pharmaceuticals Inc.

SELL

Current Price

$38.80

Market Cap

3.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BATRA
XENE
Founded
2022
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
BATRA
XENE
Price
$56.42
$38.80
Analyst Decision
Strong Buy
Analyst Count
0
18
Target Price
N/A
★ $71.56
AVG Volume (30 Days)
39.9K
★ 1.2M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 26.00
N/A
EPS
★ N/A
N/A
Revenue
★ $732,492,000.00
$311,000.00
Revenue This Year
$5.02
N/A
Revenue Next Year
$7.71
$1,985.11
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 10.52
N/A
52 Week Low
$41.50
$33.38
52 Week High
$60.48
$72.66

Technical Indicators

Market Signals
Indicator
BATRA
XENE
Relative Strength Index (RSI) 48.11 47.51
Support Level $53.98 $33.38
Resistance Level $58.19 $39.92
Average True Range (ATR) 1.26 1.44
MACD 0.13 0.45
Stochastic Oscillator 55.91 39.58

Price Performance

Historical Comparison
BATRA
XENE

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: